Abbrea Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,245
| Closed | -$284K | – | 229 |
|
|
2024
Q1 | $284K | Sell |
5,245
-599
| -10% | -$32.4K | 0.04% | 215 |
|
|
2023
Q4 | $300K | Sell |
5,844
-5,320
| -48% | -$273K | 0.04% | 201 |
|
|
2023
Q3 | $648K | Buy |
11,164
+165
| +2% | +$9.58K | 0.1% | 134 |
|
|
2023
Q2 | $703K | Buy |
10,999
+974
| +10% | +$62.3K | 0.11% | 135 |
|
|
2023
Q1 | $695K | Buy |
10,025
+150
| +2% | +$10.4K | 0.12% | 128 |
|
|
2022
Q4 | $711K | Buy |
9,875
+825
| +9% | +$59.4K | 0.13% | 126 |
|
|
2022
Q3 | $643K | Sell |
9,050
-252
| -3% | -$17.9K | 0.12% | 130 |
|
|
2022
Q2 | $721K | Sell |
9,302
-100
| -1% | -$7.75K | 0.12% | 131 |
|
|
2022
Q1 | $692K | Buy |
9,402
+255
| +3% | +$18.8K | 0.1% | 150 |
|
|
2021
Q4 | $570K | Sell |
9,147
-60
| -0.7% | -$3.74K | 0.08% | 160 |
|
|
2021
Q3 | $549K | Sell |
9,207
-1,315
| -12% | -$78.4K | 0.08% | 159 |
|
|
2021
Q2 | $703K | Buy |
10,522
+1,353
| +15% | +$90.4K | 0.11% | 139 |
|
|
2021
Q1 | $583K | Buy |
9,169
+980
| +12% | +$62.3K | 0.1% | 145 |
|
|
2020
Q4 | $512K | Buy |
8,189
+421
| +5% | +$26.3K | 0.09% | 147 |
|
|
2020
Q3 | $468K | Buy |
7,768
+892
| +13% | +$53.7K | 0.1% | 132 |
|
|
2020
Q2 | $404K | Buy |
6,876
+284
| +4% | +$16.7K | 0.09% | 145 |
|
|
2020
Q1 | $367K | Buy |
6,592
+493
| +8% | +$27.4K | 0.1% | 139 |
|
|
2019
Q4 | $392K | Buy |
+6,099
| New | +$392K | 0.08% | 145 |
|
|
2018
Q4 | – | Sell |
-4,738
| Closed | -$294K | – | 162 |
|
|
2018
Q3 | $294K | Buy |
4,738
+462
| +11% | +$28.7K | 0.09% | 150 |
|
|
2018
Q2 | $237K | Buy |
4,276
+12
| +0.3% | +$665 | 0.07% | 156 |
|
|
2018
Q1 | $270K | Buy |
4,264
+145
| +4% | +$9.18K | 0.09% | 150 |
|
|
2017
Q4 | $252K | Buy |
4,119
+356
| +9% | +$21.8K | 0.09% | 140 |
|
|
2017
Q3 | $240K | Buy |
+3,763
| New | +$240K | 0.09% | 141 |
|